Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Lai

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Hepatology (Baltimore, Md.)|October 8, 2025
Association between longitudinal weight change and clinical outcome in individuals with MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2025
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLDXiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gastroenterology|March 20, 2025
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic PerspectiveWen-Yue Liu, Shanshan Huang, Hongsheng Ji, et al.
Gut|August 1, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver diseaseXiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular RiskXiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gut|June 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLDGrazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.
Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2025
Effect of Antidiabetic Drug Classes on the Risk of Liver-Related Events in Individuals With T2D and MASLDYu Shi, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Hepatology (Baltimore, Md.)|October 8, 2025
Association between longitudinal weight change and clinical outcome in individuals with MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2025
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLDXiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gastroenterology|March 20, 2025
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic PerspectiveWen-Yue Liu, Shanshan Huang, Hongsheng Ji, et al.
Gut|August 1, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver diseaseXiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular RiskXiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gut|June 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Boyu Yang, Hye Won Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLDGrazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Pageof 16